Funded Project Details - FY2021
|Title:|| Neurosteroids in PTSD - Biomarkers to Therapeutics|
Steven T. Szabo
|Congressional District Code:
||Clinical Science R&D
|| July 2018 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Posttraumatic stress disorder (PTSD) is extremely common among Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) Veterans, impacting approximately 20% of OEF/OIF/OND Veterans enrolled in VA healthcare. Pharmacological management of PTSD is unfortunately frequently suboptimal, and many OEF/OIF/OND Veterans experience persistent and unalleviated symptoms. Currently there are only two FDA-approved pharmacological treatments for PTSD (sertraline and paroxetine, each...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.